Acute Lymphocytic Leukemia Market worth $3.780.3 Million by 2020 - New Report by MarketsandMarkets

The acute lymphoblastic leukemia therapeutics market is segmented based on the existing regimens and drugs, pipeline drugs, and geography; http://www.marketsandmarkets.com/Market-Reports/acute-lymphocytic-leukemia-therapeutics-market-518.html.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
MarketsandMarkets

MarketsandMarkets

Major Players - ERYtech Pharma (France), Talon Therapeutic, Inc. (U.S.), GlaxoSmithKline plc (U.K.), Sigma-Tau Pharmaceuticals, Inc. (U.S.), Pfizer, Inc. (U.S.), and Genzyme Corporation (U.S.)

(PRWEB) April 26, 2014

The “Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2010 - 2020)” analyzes and studies the major market drivers, restraints, and opportunities in the U.S., Canada, U.K., France, Germany, Italy, Spain, and Japan.

Browse 50 market data tables and 28 figures spread through 157 pages and in-depth TOC on"Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market"

http://www.marketsandmarkets.com/Market-Reports/acute-lymphocytic-leukemia-therapeutics-market-518.html

Early buyers will receive 10% customization on this report.

This report studies the acute lymphocytic/lymphoblastic leukemia therapeutics market, with forecast to 2020. The acute market is valued at an estimated $2,777.2 million in 2013 and is expected to reach $3,780.3 million by 2020, at a CAGR of 4.0% from 2015 to 2020.

Download Free PDf @ http://www.marketsandmarkets.com/pdfdownload.asp?id=518.

The acute lymphocytic/lymphoblastic leukemia therapeutics market has experienced stagnant growth in the past few years. The increasing incidence rate of acute lymphocytic/lymphoblastic leukemia and upcoming innovative therapies are the major factors that further propel the growth of this market. However, the high costs of therapies as well as the adverse events associated with therapies are factors that inhibit the growth of the market to a certain extent.

According to the WHO, acute lymphocytic/lymphoblastic leukemia is expected to be more widespread in the developed countries and higher socioeconomic groups, such as North America and the European countries due to genetic factors. Other causes like environmental factors and exposure to high doses of radiation are also the causative factors of all the types of acute lymphocytic/lymphoblastic leukemia.

Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=518.

Some patients experience other symptoms, such as feeling sick, having fevers, chills, night sweats and other flu-like symptoms, or feeling fatigued. Some patients experience nausea or a feeling of fullness due to an enlarged liver and spleen; this can result in unintentional weight loss. Blasts affected by the disease may come together and become swollen in the liver or in the lymph nodes causing pain and leading to nausea.

If the leukemic cells invade the central nervous system, then neurological symptoms (notably headaches) can occur. All symptoms associated with leukemia can be attributed to other diseases. Consequently, leukemia is always diagnosed through medical tests

The U.S. has the largest market in 2013 with a market share of approximately 55% to 60% of the acute lymphocytic/lymphoblastic leukemia therapeutics market in G8 countries, followed by Germany and Italy.

Major players in the market include ERYTECH Pharma (France), Talon Therapeutic, Inc. (U.S.), Pfizer, Inc. (U.S.) GlaxoSmithKline plc (U.K.), Sigma-Tau Pharmaceuticals, Inc. (U.S.), and Genzyme Corporation (U.S.).

Browse Related Reports:

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018)

http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html

Wound Care Market (Traditional Wound Care, Advanced Wound Care, Active Wound Care, Negative Pressure Wound Therapy & Other Therapy Devices) - Current Trends, Opportunities & Global Forecasts to 2016

http://www.marketsandmarkets.com/Market-Reports/wound-care-market-371.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/pharmaceuticals
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


Contact

Follow us on: Contact's Google Plus